C07K 5/10
Tetrapeptides
C07K5/10 (Tetrapeptides) appears on 2,248 US grants and 2,624 published applications in this corpus.
Search patents in C07K- Granted patents
- 2,248
- Published applications
- 2,624
- Assignees
- 1,380
- Inventors
- 5,779
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 14 | 0 |
| 1977 | 14 | 0 |
| 1978 | 22 | 0 |
| 1979 | 9 | 0 |
| 1980 | 30 | 0 |
| 1981 | 23 | 0 |
| 1982 | 20 | 0 |
| 1983 | 15 | 0 |
| 1984 | 19 | 0 |
| 1985 | 12 | 0 |
| 1986 | 12 | 0 |
| 1987 | 15 | 0 |
| 1988 | 10 | 0 |
| 1989 | 6 | 0 |
| 1990 | 9 | 0 |
| 1991 | 12 | 0 |
| 1992 | 18 | 0 |
| 1993 | 15 | 0 |
| 1994 | 20 | 0 |
| 1995 | 32 | 0 |
| 1996 | 30 | 0 |
| 1997 | 53 | 0 |
| 1998 | 73 | 0 |
| 1999 | 47 | 0 |
| 2000 | 49 | 0 |
| 2001 | 57 | 8 |
| 2002 | 46 | 57 |
| 2003 | 44 | 108 |
| 2004 | 47 | 98 |
| 2005 | 41 | 99 |
| 2006 | 65 | 96 |
| 2007 | 63 | 86 |
| 2008 | 54 | 90 |
| 2009 | 71 | 121 |
| 2010 | 80 | 119 |
| 2011 | 59 | 114 |
| 2012 | 70 | 112 |
| 2013 | 96 | 134 |
| 2014 | 108 | 131 |
| 2015 | 89 | 130 |
| 2016 | 112 | 114 |
| 2017 | 78 | 112 |
| 2018 | 74 | 125 |
| 2019 | 55 | 107 |
| 2020 | 70 | 111 |
| 2021 | 55 | 102 |
| 2022 | 54 | 82 |
| 2023 | 50 | 101 |
| 2024 | 56 | 102 |
| 2025 | 49 | 98 |
| 2026 | 26 | 67 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Polypeptide compound and use thereof in treatment of enteritis29 Sep 2026US 12,747,267 B2Sichuan Gooddoctor Panxi Pharmaceutical Co., Ltd.
- Aqueous peptide programming of the vinylidene fluoride ferroelectric phase29 Sep 2026US 12,747,302 B2Northwestern University
- Preparation method, intermediates, and use of cyclic peptide toxin alpha-amanitin and/or amaninamide1 Sep 2026US 12,723,060 B2Inner Mongolia Duhe Innovation R & D Tech Co., Ltd
- Small molecule inhibitors of SARS-CoV-2 viral replication and uses thereof25 Aug 2026US 12,715,896 B2Arizona Board of Regents on Behalf of the University of Arizona
- Inhibitors of human epididymus protein 425 Aug 2026US 12,715,897 B2University of Rochester
- Amino acid-derived ceramide, synthesis method therefor and use thereof1 Oct 2026US 2026/0297018 A1Shenzhen Dikeman Biotechnology Co., Ltd.
- Reversible surfactant and multifunctional drug delivery systems based thereon1 Oct 2026US 2026/0297127 A1Yissum Research Development Company of the Hebrew University of Jerusalem
- Universal abt compounds and uses thereof24 Sep 2026US 2026/0284204 A1Kleo Pharmaceuticals, Inc.
- Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives17 Sep 2026US 2026/0273017 A1Ambrx, Inc.
- Peptide pharmaceuticals for insulin resistance17 Sep 2026US 2026/0273069 A1Mederis Diabetes LLC
Most cited
By later US patents
- Combinatorial strategies for polymer synthesis484US 5,677,195 AAffymax Technologies N.V. · 1997
- Antibody compositions for selectively inhibiting VEGF356US 6,342,219 B12002
- Combinatorial strategies for polymer synthesis277US 6,040,193 AAffymetrix, Inc. · 2000
- Peptide library and screening systems197US 5,432,018 AAffymax Technologies N.V. · 1995
- Antibody conjugate compositions for selectively inhibiting VEGF181US 6,342,221 B12002